JP Morgan Chase’s Myomo MYO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.9K Buy
28,730
+13,928
+94% +$13.6K ﹤0.01% 6591
2026
Q1
$9.47K Sell
14,802
-22,337
-60% -$18.3K ﹤0.01% 6754
2025
Q4
$33.8K Sell
37,139
-41,137
-53% -$39.4K ﹤0.01% 6372
2025
Q3
$69.8K Sell
78,276
-59,031
-43% -$85.9K ﹤0.01% 6097
2025
Q2
$297K Buy
137,307
+27,739
+25% +$101K ﹤0.01% 5037
2025
Q1
$527K Buy
109,568
+19,421
+22% +$111K ﹤0.01% 4738
2024
Q4
$581K Buy
+90,147
New +$439K ﹤0.01% 4960
2024
Q3
Sell
-4,799
Closed -$15.4K 7580
2024
Q2
$15.4K Buy
+4,799
New +$16.3K ﹤0.01% 6188
2022
Q3
Sell
-5
Closed 6712
2022
Q2
$0 Sell
5
-1,642
-100% -$4.3K ﹤0.01% 6727
2022
Q1
$6K Buy
+1,647
New +$11K ﹤0.01% 6293

Other funds holding MYO

JP Morgan Chase's MYO Position: Q2 2026 in Review

JP Morgan Chase increased its Myomo (MYO) stake by 94% in Q2 2026, buying an estimated $13.6K and bringing the position to 28,730 shares worth $31.9K. The position accounts for ﹤0.01% of the portfolio, ranked #6591.

JP Morgan Chase first reported a position in MYO in Q1 2022 and has held it in 10 quarters since. The position peaked at $581K in Q4 2024. 80 funds tracked by Wall St. Rank hold MYO as of Q2 2026.

  • JP Morgan Chase held 28,730 shares of Myomo worth $31.9K as of Q2 2026.
  • JP Morgan Chase bought 13,928 Myomo shares in Q2 2026, an estimated $13.6K.
  • Myomo made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6591 holding.
  • JP Morgan Chase first reported a position in Myomo in Q1 2022 and has held it in 10 quarters since.
  • JP Morgan Chase's Myomo position peaked at $581K in Q4 2024.
  • 80 funds tracked by Wall St. Rank held Myomo as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.